ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 131233 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 131233; 2) Community: the network communities that were significantly associated with the response to NSC 131233; 3) Molecule: the relationships between components within communities and NSC 131233; 4) MDR: the compounds that were significantly associated with the NSC 131233.

NSC Compound Enrichment Correlation
NSC 12161 Adenosine, 1,2-dihydro-2-oxo- (9CI) 0.0385203205529754 0.18203905
NSC 127328 Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- 0.0385203205529754 0.21324304
NSC 143095 Pyrazofurin 0.0385203205529756 0.21099907
NSC 18298 Null 0.0385203205529756 0.021306047
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.0385203205529756 0.34188261
NSC 321206 Null 0.0385203205529756 0.66031035
NSC 382386 2,4-Imidazolidinedione, 3,3'-(1,6-hexanediyl)bis[5,5- diphenyl- 0.0385203205529756 -0.20444694
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.0385203205529756 0.76866622
NSC 605440 Isothiazolo[2,3-a]azepine, 5,7-bis(trifluoromethyl)- 2,3-dihydro-, 1,1-dioxide 0.0385203205529756 0.74135743
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0385203205529756 0.72763305
Total:66  Current:50    [First] [Prev] [Next] [Last]